Posters
« Back
Novel MALDI-TOF MS Workflow for Ultrahigh-Throughput Screening of Different Analytes at Each Position on a Plate
EP31456
Poster Title: Novel MALDI-TOF MS Workflow for Ultrahigh-Throughput Screening of Different Analytes at Each Position on a Plate
Submitted on 31 Mar 2020
Author(s): Sergei Dikler
Affiliations: Bruker Scientific, LLC, Billerica, MA
Poster Views: 185
View poster »

Please be aware that this Poster is viewable on an external site.


Poster Information
Abstract: MALDI-TOF mass spectrometry was established as a label-free ultrahigh-throughput screening approach for biochemical assays where substrates and products were small molecules, peptides and proteins. In this case the same list of analytes was monitored at every position on a MALDI plate. More recently, we extended this approach to screening of synthetic chemical reactions, which required monitoring different small molecule starting materials and products at every position on a MALDI plate (Figure 1). This necessitated the development of a novel software workflow and optimization of data processing methods for a dramatically increased number of analytes. This work focuses on application of the new Synthesis Screening workflow not only to screening of chemical reactions but also to screening of a custom library of small molecule pharmaceuticals.Summary: The Synthesis Screening module in the MALDI PharmaPulse software was used to screen a custom library of 41 small molecule pharmaceuticals.

The automated runs using a MALDI plate in 384 format had less than one failed plate position Results per run on average.
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Combining Imaging and OMICs: MALDI guided SpatialOMx probes proteomic mass profiles of breast cancer tumor subpopulations
Janina Oetjen 1 , Romano Hebeler 1 , Frédéric Dewez 2 , Corinna Henkel 1 , Benjamin Balluff 2 , Ron Heeren 2

FXa Anticoagulant Bioactive Proteins Derived from Scorpion Venom
Meng Li,1 Yuko P. Y. Lam,1 Peng Chen,2 Remy Gavard,1 Cookson K. C. Chiu,1 Christopher A. Wootton,1 Tomos E. Morgan,1 Qiong Wu,2 Mark P. Barrow,1 Hongzheng Fu,2 Peter B. O’Connor1

The Inhibition Pathways of Human Islet Amyloid Polypeptide
Yuko P. Y. Lam1; Cookson K.C. Chiu1; Christopher A. Wootton1; Ji-Inn Song1; Meng Li1; Ian Hands-Portman2; Mark P. Barrow1; and Peter B. O'Connor1

2D FT0ICR MS/MS analysis of IgG1
Johanna Paris 1 , Tomos E. Morgan 1 , Yuko P. Y. Lam 1 Christopher A. Wootton 1 Mark André Delsuc 2 , Mark P. Barrow 1 , John O’Hara 3 , and Peter B. O’Connor 1

High speed untargeted 4D-lipidomics LC-MS/MS workflows with Parallel Accumulation Serial Fragmentation (PASEF)
Ulrike Schweiger-Hufnagel1, Aiko Barsch1, Sven W. Meyer1